Early warning system for immunotherapy side effects
Part of Cancer clinical trials.
This study is for people with cancer who are already receiving immunotherapy (checkpoint inhibitors). It aims to build an early warning system to help detect and manage possible organ damage or other side effects from the treatment, using advanced testing to keep you safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are currently being treated with an immunotherapy drug called a checkpoint inhibitor.
- You do not have a serious autoimmune disease that is active right now.
- Your major organs (heart, lungs, liver, kidneys) are working well enough.
- You do not have an active infection that needs treatment.
- You are not pregnant or breastfeeding, and you are not allergic to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches immune system markers to see if they can predict which patients will respond well to immunotherapy and who might have side effects. If you have cancer and are starting immunotherapy, this trial may help guide future treatment decisions.
This trial aims to improve how doctors spot and track side effects from immunotherapy. If you are on or have had immunotherapy, your experience can help build a better system for monitoring these treatments.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This study looks for biological signals (biomarkers) that might predict who will experience side effects from immune checkpoint inhibitor cancer treatments. By understanding these signals early, doctors may be able to better manage or prevent serious immune-related complications.
This study looks at how immune checkpoint medicines (sometimes combined with other treatments like chemotherapy) may affect the kidneys. It may help doctors better prevent or manage kidney side effects in people starting these therapies.
This study tries to predict who is more likely to get serious side effects from immune checkpoint medicines used for solid tumors. You may help researchers by answering questionnaires before treatment and during follow-up, and by possibly storing sample specimens.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.